COVID-19 Saliva Screening Test Potential Market Study Report Based On Trend, Top Key Vendor, Size, Future Growth, Trends And Outlook

The global COVID-19 saliva screening test potential market size is expected to reach USD 3,406.2 billion by 2023, according to a new report by Grand View Research, Inc. The market is estimated to expand at a CAGR of 4.8% from 2021 to 2023. The rise in demand for rapid, efficient, saliva-based screening tests has positively impacted market growth.

This is primarily due to the various advantages offered by saliva-based tests, increasing product approvals by regulatory bodies, and a paradigm shift toward point-of-care testing. The fluorescence-labeled antigen/antibodies test is one of the recent saliva-based COVID-19 screening tests in the market which is based on the principles of fluorescence detection, biochemistry, robotics automation, and cloud computing.

As the number of people visiting public places is increasing and reaching pre-pandemic statistics in a few countries, there is a growing demand for rapid, point-of-care COVID-19 tests to mitigate viral transmission from asymptomatic people. This has enhanced the R&D for the development of simple yet effective saliva-based tests and is expected to create lucrative opportunities for several developers.

For more info visit here: https://www.grandviewresearch.com/industry-analysis/covid-19-saliva-screening-test-potential-market

COVID-19 Saliva Screening Test Potential Market Report Highlights

• The market estimates represent a potential market size for the COVID-19 saliva screening test based on the assumptions that the end-use locations have a 60% population attendance or capacity (60% of pre-COVID attendance) and the testing rate using test device is 100%
• Saliva-based tests play a vital role in screening asymptomatic individuals thereby aiding in market revenue generation in the near future
• The fluorescence-labeled antigen/antibodies test is designed to accelerate rapid point-of-access testing of individuals
• Owing to the pandemic, the economy across the various sectors is severely impacted.
• However, with the reopening of various sectors and locations such as shopping malls and amusement parks, there is a growing need for screening individuals to curb viral transmission
• In the U.S., more than 40 amusement parks have prepared to reopen by the spring of 2021, thus increasing the demand for rapid tests
• Thus, there is a high growth potential for the market with the increase in usage of the medical test at various locations to screen individuals
• Regulatory bodies such as the U.S. FDA and European Medicine Agency (EMA) have supported these products by providing EUA and product approvals
• In April 2021, Vatic Health received the CE mark for its on-the-spot’ saliva antigen test for the SARS-CoV-2 virus. The test has also completed the Medicines and Healthcare Products Regulatory Agency (MHRA) registration in the U.K.
• North America dominated the market owing to the high penetration and adoption of saliva-based screening tests in the region
• The U.S. is the major contributor to revenue generation due to the emergence of new small and mid-sized companies engaged in the development of such tests

Request a Sample Copy @ https://www.grandviewresearch.com/industry-analysis/covid-19-saliva-screening-test-potential-market/request/rs1

COVID-19 Saliva Screening Test Potential Market Segmentation

Grand View Research has segmented the global COVID-19 saliva screening test potential market on the basis of location, technology, mode, and region:

COVID-19 Saliva Screening Test Potential Location Outlook (North America) (Revenue, USD Million, 2020 - 2023)

• Travel Stations
• Airports
• Cruise
• Ports
• Train Stations
• Border Crossing
• Sports Arenas
• Concert Halls
• Shopping Malls and Centers
• Amusement Parks
• Corporate Campus Environments
• Universities & Colleges
• Factories
• Food Processing Plants
• Meat Packing Plants
• Pharmaceutical Plants
• Mining
• Retail Working Warehouses

COVID-19 Saliva Screening Test Potential Location Outlook (Other Regions) (Revenue, USD Million, 2020 - 2023)

• Travel Stations
• Sports Arenas
• Entertainment Venues
• Corporate Campus Environments
• Universities & Colleges
• Factories

COVID-19 Saliva Screening Test Potential Technology Outlook (Revenue, USD Million, 2020 - 2023)

• Fluorescence-labeled antigen/antibodies testing
• RT-PCR
• CRISPR-Cas9

COVID-19 Saliva Screening Test Potential Mode Outlook (Revenue, USD Million, 2020 - 2023)

• Centralized Testing
• Decentralized Testing

COVID-19 Saliva Screening Test Potential Regional Outlook (Revenue, USD Million, 2020 - 2023)

• North America
• U.S.
• Canada
• Europe
• Asia Pacific
• Rest of World

List of Key Players in COVID-19 Saliva Screening Test Potential Market

• FluroTech Ltd.
• ARUP Laboratories
• Vatic Health
• MOgene
• Psomagen Inc.
• DxTerity Diagnostics, Inc.
• Ambry Genetics
• Fluidigm Corporation
• Phosphorus Diagnostics LLC
• Gravity Diagnostics
• DNA Genotek, Inc.
• Quidel Corporation
• Abbott
• LumiraDX

About Grand View Research        

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more info visit @ https://www.grandviewresearch.com

 

Terminal Sterilization Services Market: Industry Analysis, Trends, Size, COVID-19 Analysis, Growth, Demand and Forecast Up to 2028

The global terminal sterilization services market size is anticipated to reach USD 19.5 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 10.3% from 2021 to 2028. The current advent of the novel COVID-19 pandemic has led to the growing demand for sterilization services and is expected to reach new frontiers in the upcoming months. As more and more people are getting infected with COVID, it is likely to create a demand for critical care equipment, which is leading to the growth of the market, globally. This is anticipated to provide plenty of opportunities for market players.

The mounting concerns over healthcare-associated infections spread through the environment or person are the major factor augmenting the market. As per CDC, in the U.S., it was estimated that HAIs account for approximately 1.7 million infections and 99,000 associated deaths each year, thus driving the market.

Growth in the pharmaceutical and biotechnology sector has had a tremendous impact on market growth. According to the Pharmaceutical Research and Manufacturers Association estimates 2018, the U.S.-based biopharmaceutical companies invested nearly USD 102.0 billion in R&D. Thus, increased R&D activities result in increased demand for various sterilization processes in these industries, thereby, fueling market growth during the forecast period.

Furthermore, the introduction of innovative products and the incorporation of new technologies by market players are expected to contribute to market growth during the forecast period. For instance, in April 2020, Matachana Group launched new steam sterilizers-MPHS Series-specifically designed to meet the guidelines of the pharmaceutical industry.

For more info visit here: https://www.grandviewresearch.com/industry-analysis/terminal-sterilization-service-market

Terminal Sterilization Services Market Report Highlights

• On the basis of product, the ethylene oxide segment dominated the market and accounted for a revenue share of 34.9% in 2020 owing to numerous advantages offered by this method such as simple penetration, large sterilizing volume, and broad material compatibility
• Based on end-use, the pharma segment dominated the market and accounted for a revenue share of 67.0% in 2020. Increasing R&D activities and the launch of complex equipment are boosting demand for the sterilization process in pharmaceutical companies
• North America dominated the market and accounted for a revenue share of 35.6% in 2020 owing to increased adoption of standard sterilization services among hospitals and research centers. Additionally, the constantly expanding patient pool is further driving the market in the region

Request a Sample Copy @ https://www.grandviewresearch.com/industry-analysis/terminal-sterilization-service-market/request/rs1

Terminal Sterilization Services Market Segmentation

Grand View Research has segmented the global terminal sterilization services market on the basis of product, end-use, and region:

Terminal Sterilization Service Product Outlook (Revenue, USD Million, 2016 - 2028)

• Ethylene Oxide
• Irradiation
• Moist Heat Terminal Sterilization
• Others

Terminal Sterilization Service End-use Outlook (Revenue, USD Million, 2016 - 2028)

• Hospitals & Clinics
• Pharma
• Others

Terminal Sterilization Service Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
• U.S.
• Canada
• Europe
• U.K.
• Germany
• France
• Italy
• Spain
• Asia Pacific
• Japan
• China
• India
• Australia
• South Korea
• Latin America
• Mexico
• Brazil
• Argentina
• Colombia
• Middle East & Africa (MEA)
• South Africa
• Saudi Arabia
• UAE

List of Key Players of Terminal Sterilization Services Market

• Steris Plc
• Getinge Group
• Advanced Sterilization Products Services, Inc.
• 3M
• Belimed
• Cantel Medical
• Matachana Group
• Sterigenics International LLC
• Olympus Corp.
• TSO3

About Grand View Research        

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more info visit @ https://www.grandviewresearch.com

 

Radiation Oncology Market Size, Share, New Trends and Future Growth Insights

The global radiation oncology market size is expected to reach USD 11.7 billion by 2028, registering a CAGR of 7.0% over the forecast period, according to a new report by Grand View Research, Inc. The rising incidence of cancer and technological advancement in radiation therapy equipment are some of the major factors driving the growth of the market.

There have been various technological advancements in radiotherapy equipment over the last decade, which has been a major factor for growth. Advancement from 2D to 3D conformal radiotherapy, motion tracking, and real-time imaging has helped improve radiation targeting and thereby reduce exposure to the surrounding healthy tissues. For instance, Accuray Incorporated introduced its motion monitoring and correction tools, Synchrony, for the Radixact device in April 2019. In contrast to traditional radiotherapy devices, this technology increases dosage accuracy and treatment times and is comparatively more effective.

Strategies such as partnerships, innovative product launches, and acquisitions are the priority of major players in the industry. For instance, in February 2020, Varian received FDA 510K clearance for its Ethos Therapy. It is an AI-driven solution designed to deliver an entire adaptive treatment plan in 15 minutes, including patient set-up to treatment delivery. In December 2019, Elekta signed a non-binding MoU with ViewRay, Inc. for the advancement of the knowledge and application of MR-LINACs.

According to an article published in Seminars in Radiation Oncology in 2017, it is expected that in low- and middle-income countries alone, more than 12,000 additional treatment machines will be needed by 2035. Besides, by 2035, it is projected that China, India, and Brazil will need over 3,800, 1,200, and 400 additional equipment, respectively. Companies are taking several initiatives to meet this demand. For instance, in 2019, Tata Trust signed a 3-year agreement with Varian Medical Systems Inc. for the installation of new advanced radiotherapy equipment in India, to improve patient access to treatment.

However, the lack of skilled radiotherapy professionals is expected to be a major restraining factor for the growth of the market, particularly in developing countries. The recommended number of radiation oncologists in the developed world is around 4 per million population. There are around 0.8 radiation oncologists per million population in India. Similar is the situation in other countries in the Indian sub-continent.

For more info visit here: https://www.grandviewresearch.com/industry-analysis/radiation-oncology-market

Radiation Oncology Market Report Highlights

• Due to the high availability of External Beam Radiation Therapy (EBRT) equipment and penetration of innovative diagnostic instruments and understanding of available treatment options, EBRT dominated the market in 2020
• In IBRT application, the prostate cancer segment dominated the market in 2020, majorly due to the promising applications for brachytherapy in the treatment of prostate cancer
• In 2020, North America dominated the market and accounted for a revenue share of more than 44.0%. Favorable reimbursement policies, quality of healthcare infrastructure, and the presence of key players in the region are some of the factors driving the market in the region

Request a Sample Copy @ https://www.grandviewresearch.com/industry-analysis/radiation-oncology-market/request/rs1

About Grand View Research        

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more info visit @ https://www.grandviewresearch.com

 

Wearable Injectors Market Future Growth & Latest Trends

The global wearable injectors market size is expected to reach USD 18.3 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 17.2% from 2021 to 2028. Wearable injectors are drug administration devices designed to deliver drugs in large volumes subcutaneously. It is gaining popularity owing to its advantages such as reduced pain, ease of administration, and elimination of costly health facility visits.

Over the last decade, patient interest in the self-administration of injectable drug therapies has grown. The increasing prevalence of diabetes, chronic pain, and auto-immune diseases, such as rheumatoid arthritis, is increasing the use of wearable injectors. Their demand is increasing for the long-term management of asthma, chronic obstructive pulmonary disease (COPD), high cholesterol, and cancer. This is expected to create a lucrative opportunity for advanced device manufacturers to make wearable devices used to administer larger dose volumes at the comfort of home.

The recent COVID-19 pandemic has brought remote care technologies, such as wearable injectors, into the spotlight. Demand for chronic disease products remains largely unaffected by the pandemic. Since wearable injectors serve with the option of delivering medications at home, its demand has also remained stable or rather grown for the short term. Patients suffering from chronic diseases are opting for these devices as it reduces the risk of exposure to COVID-19 by eliminating hospital visits. The pandemic has, however, affected some of the devices in the pipeline, affecting short-term investments. Leading players who continue to invest in innovation push projects forward despite COVID-19 are expected to put their companies in a stronger competitive position post-crisis.

For more info visit here: https://www.grandviewresearch.com/industry-analysis/wearable-injectors-market

Wearable Injectors Market Report Highlights

• By type, the on-body segment led the market in 2020 owing to its advantage to be worn on the skin
• The spring-based technology segment held the largest share of 36.3% in 2020 due to a rise in demand for adhesive patches for the treatment of chronic conditions, such as cancer and diabetes
• The home care end-use segment led the market in 2020. This can be attributed to a rise in preference for self-administration, especially during the COVID-19 pandemic
• North America dominated the market with a share of 41.5% in 2020 owing to the rising prevalence of chronic diseases

Request a Sample Copy @ https://www.grandviewresearch.com/industry-analysis/wearable-injectors-market/request/rs1

Wearable Injectors Market Segmentation

Grand View Research has segmented the global wearable injectors market based on type, technology, application, end-use, and region:

Wearable Injectors Type Outlook (Revenue, USD Million, 2016 - 2028)

• On-body
• Off-body

Wearable Injectors Technology Outlook (Revenue, USD Million, 2016 - 2028)

• Spring-based
• Motor-driven
• Rotary Pump
• Expanding Battery
• Others

Wearable Injectors Application Outlook (Revenue, USD Million, 2016 - 2028)

• Oncology
• Infectious Diseases
• Cardiovascular Diseases
• Autoimmune Diseases
• Others

Wearable Injectors End-use Outlook (Revenue, USD Million, 2016 - 2028)

• Hospitals
• Clinics
• Home Care
• Others

Wearable Injectors Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
• U.S.
• Canada
• Europe
• U.K.
• Germany
• France
• Asia Pacific
• Japan
• China
• Latin America
• Brazil
• Mexico
• Middle East & Africa
• South Africa

List of Key Players of Wearable Injectors Market

• Becton, Dickinson and Company
• Johnson & Johnson Services, Inc.
• F. Hoffmann-La Roche Ltd.
• Unilife Corporation
• SteadyMed Therapeutics, Inc.
• Amgen, Inc.
• Insulet Corporation
• Enable Injections
• West Pharmaceutical Services, Inc.
• CeQur SA

About Grand View Research        

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more info visit @ https://www.grandviewresearch.com

 

 

Controlled Release Drug Delivery Market Outlook, Share and Future Growth Analysis, Size, Development Factors

The global controlled release drug delivery market size is estimated to reach USD 69.8 billion by 2027 registering a CAGR of 7.8% during the forecast period, according to a new report by Grand View Research, Inc. The benefits associated with controlled release drug delivery systems, such as increased therapeutic efficacy, less side effects, and low treatment cost are the factors driving the market growth.

These technologies offer various benefits over traditional delivery forms, such as reduced dosage and dosage frequency, enhanced patient compliance, less gastrointestinal side effects, uniform drug effect, improved drug efficacy and safety, and reduced fluctuation of plasma drug levels.

Presence of multiple in-vivo biological barriers that affects the absorption, bioavailability, and stability of the drug has open wide horizon for the controlled release drug delivery products. For instance, controlled release drug delivery system has enabled delivery of even large and complex molecules such as DNA/RNA, proteins and polypeptides. Additionally, the rising awareness among healthcare professionals, regarding the advantage of controlled release drug delivery systems over conventional systems is expected to drive the demand for the market in long run.

Rapidly increasing geriatric and pediatric population is one of the major factors fueling the demand for controlled release drug delivery systems, due to high cases prescription non-adherence in this age-group. Innovations in various drug delivery systems has been providing geriatric and pediatric population with easy solutions, which are further propelling the market. Controlled release of drug delivery systems can be altered according to required dosage over a specific period of time.

For more info visit here: https://www.grandviewresearch.com/industry-analysis/controlled-release-drug-delivery-market

Controlled Release Drug Delivery Market Report Highlights

• Based on application, oral controlled release systems held the largest market share in 2019 owing to increasing usage and ease of convenience offered for administration of medication
• Targeted drug delivery is poised to be the fastest growing technology segment during the forecast period owing to various benefits of the technology, such as increased safety and therapeutic efficacy
• Osmotic delivery is projected to witness the fastest CAGR in the activation modulation drug delivery systems during the forecast period, due to the ability of this release mechanism to not be affected by various factors, such as pH, food consumption, and gastrointestinal motility
• North America held the largest market share in 2019 owing to the presence of developed healthcare infrastructure facilities, increasing R&D activities and existence of major market players
• Asia Pacific is expected to post the highest CAGR during the forecast period owing to rising investments by dominant players in the region along with developments in the of pharmaceutical industry in emerging countries, such as India and China
• Some of the prominent companies operating in the controlled release drug delivery market are Orbis Biosciences, Inc.; Merck and Co., Inc.; Alkermes plc; Johnson and Johnson; Coating Place, Inc.; Corium International, Inc.; Depomed, Inc.; Pfizer, Inc; Aradigm Corporation; and Capsugel

Request a Sample Copy @ https://www.grandviewresearch.com/industry-analysis/controlled-release-drug-delivery-market/request/rs1

Controlled Release Drug Delivery Market Segmentation

Grand View Research has segmented the global controlled release drug delivery market on the basis of technology, release mechanism, application, and region:

Controlled Release Drug Delivery Technology Outlook (Revenue, USD Million, 2016 - 2027)

• Wurster Technique
• Coacervation
• Micro Encapsulation
• Implants
• Transdermal
• Targeted Delivery
• Others

Controlled Release Drug Delivery Release Mechanism Outlook (Revenue, USD Million, 2016 - 2027)

• Polymer Based Systems
• Micro Reservoir Partition Controlled Drug Delivery Systems
• Feedback Regulated Drug Delivery Systems
• Activation-modulated Drug Delivery Systems
• Osmotic Pressure Activated
• Hydrodynamic Pressure Activated
• Vapor Pressure Activated
• Mechanically Activated
• Magnetically Activated
• Chemically Activated
• pH Activated
• Hydrolysis Activated
• Enzyme Activated

Controlled Release Drug Delivery Application Outlook (Revenue, USD Million, 2016 - 2027)

• Metered Dose Inhalers
• Injectable
• Transdermal and Ocular Patches
• Infusion Pumps
• Oral Controlled-drug Delivery Systems
• Drug Eluting Stents

Controlled Release Drug Delivery Region Outlook (Revenue, USD Million, 2016 - 2027)

• North America
• U.S.
• Canada
• Europe
• Germany
• UK
• France
• Italy
• Russia
• Switzerland
• Netherland
• Sweden
• Spain
• Belgium
• Asia Pacific
• China
• Japan
• India
• Thailand
• South Korea
• Singapore
• Philippines
• Vietnam
• Indonesia
• Malaysia
• Latin America
• Brazil
• Mexico
• Argentina
• Colombia
• Chile
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE
• Israel
• Kuwait

About Grand View Research        

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more info visit @ https://www.grandviewresearch.com